Published DateClear

Start Date

End Date

Category

• Products3

Organizations

• Bausch + Lomb66
• Eyes On Eyecare51
• Alcon, Inc.46
• American Optometric Association37
• Harrow30
• Glaukos27
• Topcon Healthcare25
• Regeneron24
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA3
• Eye Drops3
• Generics3
• Products3
• Fda Approval2
• Eye Drop Solution2
• IOP1
• Ocular Hypertension1
• Corticosteroids1
• Glaucoma1

• Organizations: Alembic Pharmaceuticals✕

Clear all

Products

FDA approves Alembic's difluprednate 0.05% generic

Generic version of Sandoz’s Durezol is indicated for postop pain and inflammation as well as endogenous anterior uveitis.

Products

FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension

Generic of Bausch + Lomb’s ZYLET for steroid-responsive inflammatory ocular conditions qualifies for 6 months of market exclusivity once commercially launched.

Products

Generic brimonidine ophthalmic solution launches for IOP reduction

Alembic Pharmaceuticals’ generic formulation is indicated to reduce IOP in patients with OAG and OHT.